Φορτώνει......
Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity
PURPOSE: Anticancer drug delivery systems are often limited by hurdles, such as off-target distribution, slow cellular internalization, limited lysosomal escape, and drug resistance. To overcome these limitations, we have developed a stable nitric oxide (NO)-releasing nanoparticle (polystyrene-malei...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Nanomedicine |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251458/ https://ncbi.nlm.nih.gov/pubmed/30538458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S187089 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|